We hereby attaching you the intimation under regulation 31A(10) of SEBI(LODR) Regulation, 2015 for reclassification of promoter to public pursuant to open offer.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 3.6 pts more than Nifty Microcap 250 and 3.9 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Oxygenta Pharmaceutical Ltd has informed BSE that its existing Promoter and Promoter Group members have been reclassified to the Public Category following a Share Purchase Agreement dated September 30, 2024 with M/s Virupaksha Organics Limited (the Acquirer). A total of 23,22,018 shares (6.28%) held by eight outgoing promoter/promoter group entities have moved to the public category. Post reclassification, Virupaksha Organics Limited holds 2,04,77,458 equity shares (55.37%), making it the new holding company, with the new promoter group collectively holding 57.92%. The change of control has triggered a reconstitution of the Board of Directors, effected at a board meeting held on June 20, 2025. This complies with Regulation 31A(10) of SEBI LODR Regulations, 2015, read with SEBI (SAST) Regulations, 2011, following the open offer process.
The company has undergone a complete change of control with a new promoter — Virupaksha Organics Limited — now holding a majority 55.37% stake. Shareholders should expect new management direction, potential strategic shifts, and possible re-rating of the stock as the new promoter consolidates its position; minority shareholders now fall under the new promoter group's governance.